John McShane

Director, Business Development - East Coast USA and Canada

John is a co-founder of the Boston Epigenetics Society and an award-winning sales executive with a demonstrated history of working in biotechnology.

Skilled in:

  • Next-generation sequencing
  • Epigenetics
  • Proteomics
  • Lab automation
  • Liquid handling
  • Capital equipment
  • Medical devices
  • Robotics
  • Analytical chemistry
  • Research consumables

biomodal is an omics-based life sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus.

John can guide you through our duet multiomics solution which enables more epigenetic information from a single, low-input DNA library without complex, resource-intensive bioinformatics or harsh chemical treatment.

Get in touch

Cambridge Epigenetix is now biomodal